NomadX
J. Christopher Ellis is a highly experienced professional in the fields of computational biology and bioinformatics, currently serving as Chief Scientific Officer at NomadX since 2024. Previous roles include Senior Director of Computational Biology at BiomEdit and a position at Oak Ridge National Laboratory. Ellis has an extensive background with Eli Lilly and Company, where roles included Head of Microbiology & NGS/Informatics Labs in Research and Development. As the Founder and CEO of In Silico LLC, expertise was further developed. Academic achievements include a PhD in Microbiology from North Carolina State University, along with positions at Duke University and the National Institute of Environmental Health Sciences as a postdoctoral fellow.
This person is not in any teams
This person is not in any offices
NomadX
The natural selection in the evolution of diagnostics. NOMADX is pioneering new technologies for biological detection that include innovative products that will enable faster, more accurate pathogen testing in food. NOMADX cartridge-enhanced Surface-Enhanced Raman Scattering platform is a patented surface coating that is applied to silicon chips using metallic nanoparticles. The technology significantly enhances the electromagnetic and chemical spectral scattering signal of molecules within a sample to create a multiplex platform. Studies have shown that the platform is as fast and simple to use as an ATP-based test, with results that can exceed the sensitivity, specificity, and speed of traditional PCR testing.